NRSN (NeuroSense Therapeutics) Dividend Yield % : 0.00% (As of Dec. 12, 2024)

View and export this data going back to 2021. Start your Free Trial

What is NeuroSense Therapeutics Dividend Yield %?

As of today (2024-12-12), the Trailing Annual Dividend Yield of NeuroSense Therapeutics is 0.00%.

The historical rank and industry rank for NeuroSense Therapeutics's Dividend Yield % or its related term are showing as below:

NRSN's Dividend Yield % is not ranked ^*
in the Biotechnology industry.
Industry Median: 1.4
* Ranked among companies with meaningful Dividend Yield % only.

NeuroSense Therapeutics's Dividend Payout Ratio for the three months ended in Jun. 2024 was 0.00.

As of today (2024-12-12), the Forward Dividend Yield % of NeuroSense Therapeutics is 0.00%.

NeuroSense Therapeutics's Dividends per Share for the three months ended in Jun. 2024 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

NeuroSense Therapeutics Dividend Yield % Historical Data

The historical data trend for NeuroSense Therapeutics's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NeuroSense Therapeutics Dividend Yield % Chart

NeuroSense Therapeutics Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dividend Yield %

NeuroSense Therapeutics Quarterly Data
	Dec19	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Dividend Yield %	Get a 7-Day Free Trial												-	-	-	-	-

Competitive Comparison of NeuroSense Therapeutics's Dividend Yield %

For the Biotechnology subindustry, NeuroSense Therapeutics's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NeuroSense Therapeutics's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NeuroSense Therapeutics's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where NeuroSense Therapeutics's Dividend Yield % falls into.

NeuroSense Therapeutics Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

NeuroSense Therapeutics (NAS:NRSN) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

NeuroSense Therapeutics Dividend Yield % Related Terms

Thank you for viewing the detailed overview of NeuroSense Therapeutics's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

NeuroSense Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NeuroSense Therapeutics Ltd (NAS:NRSN) » Definitions » Dividend Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

11 HaMenofim Street, Building B, Herzliya, ISR, 4672562

Website

https://www.neurosense-tx.com

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, these diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.